DS
CYRX icon

David Shaw’s CryoPort CYRX Stock Holding History

David Shaw’s Portfolio CYRX Stock Details CYRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.53M Buy
479,625
+321,400
+203% +$4.12M ﹤0.01% 2076
2026
Q1 		$1.31M Sell
158,225
-91,078
-37% -$823K ﹤0.01% 3239
2025
Q4 		$2.39M Sell
249,303
-137,492
-36% -$1.3M ﹤0.01% 2915
2025
Q3 		$3.67M Buy
386,795
+4,116
+1% +$34.6K ﹤0.01% 2484
2025
Q2 		$2.85M Buy
382,679
+52,242
+16% +$324K ﹤0.01% 2472
2025
Q1 		$2.01M Sell
330,437
-77,948
-19% -$539K ﹤0.01% 2594
2024
Q4 		$3.18M Buy
408,385
+68,474
+20% +$510K ﹤0.01% 2353
2024
Q3 		$2.76M Buy
339,911
+226,964
+201% +$1.86M ﹤0.01% 2443
2024
Q2 		$780K Sell
112,947
-24,484
-18% -$330K ﹤0.01% 3343
2024
Q1 		$2.43M Sell
137,431
-52,134
-28% -$825K ﹤0.01% 2476
2023
Q4 		$2.94M Buy
+189,565
New +$2.48M ﹤0.01% 2353
2023
Q3 		– Sell
-41,110
Closed -$709K – 4296
2023
Q2 		$709K Sell
41,110
-49,354
-55% -$1.01M ﹤0.01% 3259
2023
Q1 		$2.17M Buy
90,464
+11,841
+15% +$257K ﹤0.01% 2631
2022
Q4 		$1.36M Buy
+78,623
New +$1.66M ﹤0.01% 3226
2021
Q3 		– Sell
-6,698
Closed -$413K – 5014
2021
Q2 		$423K Sell
6,698
-49,563
-88% -$2.79M ﹤0.01% 4111
2021
Q1 		$2.93M Sell
56,261
-270,710
-83% -$16.5M ﹤0.01% 2254
2020
Q4 		$14.3M Sell
326,971
-84,376
-21% -$4.02M 0.01% 1151
2020
Q3 		$19.5M Buy
411,347
+380,096
+1,216% +$15.4M 0.02% 849
2020
Q2 		$945K Sell
31,251
-83,230
-73% -$1.85M ﹤0.01% 2983
2020
Q1 		$1.95M Sell
114,481
-18,183
-14% -$318K ﹤0.01% 2190
2019
Q4 		$2.18M Sell
132,664
-118,671
-47% -$1.77M ﹤0.01% 2393
2019
Q3 		$4.11M Buy
251,335
+202,906
+419% +$4.07M 0.01% 1799
2019
Q2 		$887K Buy
48,429
+783
+2% +$12.4K ﹤0.01% 2748
2019
Q1 		$616K Buy
+47,646
New +$518K ﹤0.01% 2889
2018
Q4 		– Sell
-21,764
Closed -$279K – 3796
2018
Q3 		$279K Buy
+21,764
New +$311K ﹤0.01% 3390

Other funds holding CYRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

David Shaw's CYRX Position: Q2 2026 in Review

David Shaw increased its CryoPort (CYRX) stake by 203% in Q2 2026, buying an estimated $4.12M and bringing the position to 479,625 shares worth $7.53M. The position accounts for ﹤0.01% of the portfolio, ranked #2076.

David Shaw first reported a position in CYRX in Q3 2018 and has held it in 25 quarters since. The position peaked at $19.5M in Q3 2020. 185 funds tracked by Wall St. Rank hold CYRX as of Q2 2026.

  • David Shaw held 479,625 shares of CryoPort worth $7.53M as of Q2 2026.
  • David Shaw bought 321,400 CryoPort shares in Q2 2026, an estimated $4.12M.
  • CryoPort made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #2076 holding.
  • David Shaw first reported a position in CryoPort in Q3 2018 and has held it in 25 quarters since.
  • David Shaw's CryoPort position peaked at $19.5M in Q3 2020.
  • 185 funds tracked by Wall St. Rank held CryoPort as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.